Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06162767
Status:
RECRUITING
Last Update Posted:
2024-03-21
First Post:
2023-11-14
Brief Title:
Cancer of Esophagogastric Junction Optimized Sweet Versus Ivor-Lewis
Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Organization:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Study Overview
Official Title:
A Randomized Controlled Study of Optimized Sweet Procedure Versus Ivor-Lewis Procedure Esophagectomy in Adenocarcinoma of Esophagogastric Junction
Status:
RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being done to see whether Optimized Sweet Procedure is superior than the Ivor-Lewis Procedure Esophagectomy with better long-term outcome and acceptable postoperative short-term outcome or not
Detailed Description:
Esophagogastric junction carcinoma is a prevalent malignancy within the human digestive system ranking as the sixth leading cause of cancer-related deaths worldwide Current national and international guidelines advocate for a comprehensive approach primarily centered around surgical intervention for the management of esophagogastric junction carcinoma This preference stems from the fact that lymph node metastasis in such patients can occur simultaneously in the abdominal region and the lower mediastinum Consequently conventional options like the Ivor Lewis and Sweet procedures are routinely recommended due to their capability to encompass tumor resection margin clearance and lymph node dissection However traditional Sweet procedures are associated with higher surgical trauma and increased postoperative complications With the evolution of single-incision thoracoscopy we have leveraged the advantages of minimally invasive techniques and innovatively devised an Optimized totally thoracoscopic Sweet procedureIn this study a randomized controlled trial will enroll 240 patients diagnosed with esophagogastric junction carcinoma to compare the therapeutic efficacy between the Optimized Sweet Procedure and the Ivor-Lewis Procedure Postoperative follow-ups will be conducted to analyze pre-discharge indicators and five-year postoperative outcomes examining the correlation between the two surgical procedures in terms of postoperative quality of life mortality rates and survival rates aiming to explore whether the Optimized Sweet Procedure is superior to the Ivor-Lewis Procedure Esophagectomy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None